Literature DB >> 12086099

Apolipoprotein E genotype, lipid levels and coronary heart disease in a Polish population group.

M Bednarska-Makaruk1, G Broda, P Kurjata, M Rodo, M Roszczynko, S Rywik, H Wehr.   

Abstract

Genotype of apolipoprotein E has been identified in a group of randomly selected Polish subjects participating in a cross-sectional study performed within the POL-MONICA Program, the part of international study WHO-MONICA Project. The investigated group consisted of 170 persons, 92 males and 78 females aged 41-69 years (mean age 62.0+/-5.11). The observed frequency of apolipoprotein E alleles was: epsilon2 - 7.6%, epsilon3 - 81.8% and epsilon4 - 10.6%, which was similar to frequencies in the neighbouring European countries. Statistically significant lower means of total cholesterol (TC) and of low density lipoprotein cholesterol (LDL-C) levels in epsilon2 carriers and higher means of TC, of LDL-C and of triglycerides in epsilon4 carriers were observed as compared with noncarriers of respective alleles. Some nonlipid cardiovascular risk factors (hypertension (HT) and obesity) and coronary heart disease (CHD) showed a tendency to lower prevalence in the epsilon2 allele carriers as compared to noncarriers. In the epsilon4 allele carriers a tendency to higher prevalence of HT, but not of CHD was observed as compared to noncarriers of this allele.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12086099     DOI: 10.1023/a:1015657709060

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  17 in total

1.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

2.  The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe.

Authors:  S Sans; H Kesteloot; D Kromhout
Journal:  Eur Heart J       Date:  1997-08       Impact factor: 29.983

3.  Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography.

Authors:  X L Wang; R M McCredie; D E Wilcken
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-08       Impact factor: 8.311

4.  Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study.

Authors:  C Lahoz; E J Schaefer; L A Cupples; P W Wilson; D Levy; D Osgood; S Parpos; J Pedro-Botet; J A Daly; J M Ordovas
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

5.  Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease.

Authors:  L Chambless; U Keil; A Dobson; M Mähönen; K Kuulasmaa; A M Rajakangas; H Löwel; H Tunstall-Pedoe
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

6.  Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study.

Authors:  R Frikke-Schmidt; A Tybjaerg-Hansen; R Steffensen; G Jensen; B G Nordestgaard
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

7.  Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors.

Authors:  K Bohnet; T Pillot; S Visvikis; N Sabolovic; G Siest
Journal:  J Lipid Res       Date:  1996-06       Impact factor: 5.922

8.  Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.

Authors:  Y A Kesäniemi; C Ehnholm; T A Miettinen
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

9.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.

Authors:  J Dallongeville; S Lussier-Cacan; J Davignon
Journal:  J Lipid Res       Date:  1992-04       Impact factor: 5.922

Review 10.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb
View more
  5 in total

1.  Apolipoprotein E (ApoE) polymorphism is related to differences in potential fertility in women: a case of antagonistic pleiotropy?

Authors:  Grazyna Jasienska; Peter T Ellison; Andrzej Galbarczyk; Michal Jasienski; Malgorzata Kalemba-Drozdz; Maria Kapiszewska; Ilona Nenko; Inger Thune; Anna Ziomkiewicz
Journal:  Proc Biol Sci       Date:  2015-03-22       Impact factor: 5.349

2.  No change of the lipid profile under the control of ApoE gene polymorphism in schizophrenics under paliperidone treatment.

Authors:  Wei-Tsung Kao; Chen-Lin Chang; Yi-Lung Chen; For-Wey Lung
Journal:  Psychiatr Q       Date:  2014-12

3.  Apolipoprotein E variants correlate with the clinical presentation of paediatric inflammatory bowel disease: A cross-sectional study.

Authors:  Aleksandra Glapa-Nowak; Mariusz Szczepanik; Barbara Iwańczak; Jarosław Kwiecień; Anna Barbara Szaflarska-Popławska; Urszula Grzybowska-Chlebowczyk; Marcin Osiecki; Marcin Dziekiewicz; Andrzej Stawarski; Jarosław Kierkuś; Tomasz Banasiewicz; Aleksandra Banaszkiewicz; Jarosław Walkowiak
Journal:  World J Gastroenterol       Date:  2021-04-14       Impact factor: 5.742

Review 4.  Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.

Authors:  Inga Kuhlmann; Anne Marie Minihane; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876

5.  Associations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population.

Authors:  Janina Petkeviciene; Alina Smalinskiene; Dalia Ieva Luksiene; Kristina Jureniene; Vitalija Ramazauskiene; Jurate Klumbiene; Vaiva Lesauskaite
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.